Serum endocan level and its prognostic significance in breast cancer patients
- 期刊名称Journal of Oncological Sciences
- 作者Ates, Ozturk; Gedik, Emre; Sunar, Veli; Altundag, Kadri
- 印刷ISSN2452-3364
- 文件大小313.12KB
- 发表时间2017-12
- DOI10.1016/j.jons.2017.11.004
Targeted treatment of hypereosinophilic syndromes and chronic eosinophilic leukemias with imatinib mesylateSteven Coutré; Jason Gotlib · 2004
Targeted treatment of hypereosinophilic syndromes and chronic eosinophilic leukemias with imatinib mesylate”: Steven Coutré and Jason Gotlib [Seminars in Cancer Biology 14 (1) (2004) 23–312004
Targeted treatment of hypereosinophilic syndromes and chronic eosinophilic leukemias with imatinib mesylateSteven Coutré; Jason Gotlib · 2004
Salvage therapy with mitoxantrone, etoposide and cytarabine in relapsed or refractory acute lymphoblastic leukemiaLiedtke, Michaela; Dunn, Tamara; Dinner, Shira; Coutré, Steven E.; Berube, Caroline; Gotlib, Jason; Patel, Samit; Medeiros, Bruno · Leukemia Research · 2014
A phase 1, open-label, dose-escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myelomaDunn, Tamara J.; Dinner, Shira; Price, Elizabeth; Coutré, Steven E.; Gotlib, Jason; Hao, Ying; Berube, Caroline; Medeiros, Bruno C.; Liedtke, Michaela · British Journal of Haematology · 2016
A phase I, open-label, dose-escalation study of amrubicin in combination with lenalidomide and weekly dexamethasone in previously treated adults with relapsed or refractory multiple myelomaDinner, Shira; Dunn, Tamara J.; Price, Elizabeth; Coutré, Steven E.; Gotlib, Jason; Berube, Caroline; Kaufman, Gregory P.; Medeiros, Bruno C.; Liedtke, Michaela · International Journal of Hematology · 2018